Validity, Reliability, and Sensitivity of a 3D Vision Sensor-based Upper Extremity Reachable Workspace Evaluation in Neuromuscular Diseases
暂无分享,去创建一个
Ruzena Bajcsy | Gregorij Kurillo | Jay J. Han | Alina Nicorici | R. Ted Abresch | R. Bajcsy | G. Kurillo | R. Abresch | A. Nicorici
[1] R. H. Jebsen,et al. An objective and standardized test of hand function. , 1969, Archives of physical medicine and rehabilitation.
[2] M. Province,et al. Reliability of goniometric measurements in patients with Duchenne muscular dystrophy. , 1985, Physical therapy.
[3] W. Stuberg,et al. Reliability of quantitative muscle testing in healthy children and in children with Duchenne muscular dystrophy using a hand-held dynamometer. , 1988, Physical therapy.
[4] L. Hiller,et al. Upper extremity functional assessment scales in children with Duchenne muscular dystrophy: a comparison. , 1992, Archives of physical medicine and rehabilitation.
[5] James G Wright,et al. Erratum: Development of an upper extremity outcome measure: The DASH (Disabilities of the Arm, Shoulder, and Hand) (American Journal of Industrial Medicine (1996) 29:6 (602-608)) , 1996 .
[6] C Disselhorst-Klug,et al. A marker-based measurement procedure for unconstrained wrist and elbow motions. , 1999, Journal of biomechanics.
[7] James G Wright,et al. Measuring disability of the upper extremity: a rationale supporting the use of a regional outcome measure. , 1999, Journal of hand therapy : official journal of the American Society of Hand Therapists.
[8] Clark C. Presson,et al. Normative and Validation Studies of the Nine-Hole Peg Test with Children , 2000, Perceptual and motor skills.
[9] Jadran Lenarčič,et al. Kinematic Model for Determination of Human Arm Reachable Workspace , 2005 .
[10] N Klopcar,et al. A kinematic model of the shoulder complex to evaluate the arm-reachable workspace. , 2007, Journal of biomechanics.
[11] F. Muntoni. The development of antisense oligonucleotide therapies for Duchenne muscular dystrophy: Report on a TREAT-NMD workshop hosted by the European Medicines Agency (EMA), on September 25th 2009 , 2010, Neuromuscular Disorders.
[12] K. Bushby,et al. Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings. , 2011, Clinical investigation.
[13] Marjorie Skubic,et al. Evaluation of an inexpensive depth camera for in-home gait assessment , 2011, J. Ambient Intell. Smart Environ..
[14] H. Stam,et al. Upper limb function in adults with Duchenne muscular dystrophy. , 2011, Journal of rehabilitation medicine.
[15] Ruzena Bajcsy,et al. Development and Application of Stereo Camera-Based Upper Extremity Workspace Evaluation in Patients with Neuromuscular Diseases , 2012, PloS one.
[16] Linda Denehy,et al. Validity of the Microsoft Kinect for assessment of postural control. , 2012, Gait & posture.
[17] Stepán Obdrzálek,et al. Accuracy and robustness of Kinect pose estimation in the context of coaching of elderly population , 2012, 2012 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.
[18] E. Mazzone,et al. A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy , 2012, Developmental medicine and child neurology.
[19] Albert A. Rizzo,et al. Towards pervasive physical rehabilitation using Microsoft Kinect , 2012, 2012 6th International Conference on Pervasive Computing Technologies for Healthcare (PervasiveHealth) and Workshops.
[20] Stepán Obdrzálek,et al. Upper Extremity Reachable Workspace Evaluation with Kinect , 2013, MMVR.
[21] Lise Worthen-Chaudhari,et al. Proof of Concept of the Ability of the Kinect to Quantify Upper Extremity Function in Dystrophinopathy , 2013, PLoS currents.